Stilonium | 778527-06-3

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 二苯乙烯类
• 英文名称: Stilonium
• 英文别名: triethyl-[2-[4-[(E)-2-phenylethenyl]phenoxy]ethyl]azanium
• CAS: 778527-06-3
• 化学式: C22H30NO+
• 分子量: 324.5
• InChiKey: YIMFXBPXUPTIEJ-OUKQBFOZSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.3
• 重原子数：
  24
• 可旋转键数：
  9
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

文献信息

• COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS
  申请人：Miller Freda

  公开号：US20110301105A1

  公开（公告）日：2011-12-08

  We have discovered that p63 inhibition results in increased cellular proliferation. We have also performed a screen for agents capable of increasing cellular proliferation, (e.g., of stem cells such as skin-derived precursors (SKPs)). The invention therefore invention provides compositions, methods, and kits for increasing proliferation of cells, using compounds that decrease p63 expression or activity or using the compounds described herein. The invention also features methods of using these compounds for increasing hair growth, improving skin health, or promoting skin repair in a subject.
• US8748177B2
  申请人：——

  公开号：US8748177B2

  公开（公告）日：2014-06-10
• [EN] COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS<br/>[FR] COMPOSITIONS POUR LA PROLIFÉRATION DE CELLULES ET PROCÉDÉS ASSOCIÉS
  申请人：HOSPITAL FOR SICK CHILDREN

  公开号：WO2010039679A1

  公开（公告）日：2010-04-08

  We have discovered that p63 inhibition results in increased cellular proliferation. We have also performed a screen for agents capable of increasing cellular proliferation, (e.g., of stem cells such as skin-derived precursors (SKPs)). The invention therefore invention provides compositions, methods, and kits for increasing proliferation of cells, using compounds that decrease p63 expression or activity or using the compounds described herein. The invention also features methods of using these compounds for increasing hair growth, improving skin health, or promoting skin repair in a subject.
• [EN] BMP-MIMETICS<br/>[FR] MIMÉTIQUES DE BMP
  申请人：UNIV DORTMUND TECH

  公开号：WO2019042889A1

  公开（公告）日：2019-03-07

  The present invention relates to a method for differentiating, transdifferentiating or reprogramming a cell by contacting a cell with a compound as defined in the present invention. The invention further relates to said compounds as defined in the present invention for use in the treatment of osteoporosis, bone fracture, osteonecrosis, osteoarthritis, rheumatoid arthritis, spondylosis, anterior lumbar fusion or long bone fracture and to a method for determining bone morphogenetic protein (BMP) mimetic activity of a compound of interest.